NCT05431595View on ClinicalTrials.gov

Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
DeliriumEpilepticsNeuroleptics
Interventions
DRUG

Haloperidol

Given by Vein (IV)

DRUG

Chlorpromazine

Given by Vein (IV)

DRUG

Valproate

Given by Vein (IV)

DRUG

Placebo

Given by Vein (IV)

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

M.D. Anderson Cancer Center

OTHER